From Bailout to Benchmark: Rethinking the Alfieri Procedure for Mitral Regurgitation in Barlow’s Disease
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817343 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von K. Steiner und 9 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
The treatment of mitral regurgitation (MR) due to Barlow’s disease remains a significant surgical challenge. Various repair techniques have been developed, with the Alfieri procedure gaining increasing popularity. Nevertheless, many surgeons continue to apply this technique mainly as a bailout strategy. We assessed the Alfieri edge-to-edge as a deliberate, reliable, and durable approach to mitral valve repair.
Methods
From the institutional database, we conducted a retrospective analysis of patients undergoing surgical repair for severe Barlow-related MR (2007–2023). Patients were treated with either Alfieri or neochordal repair. The primary endpoints were long-term durability and safety, assessed by echocardiography and clinical follow-up (FU).
Results
We screened a total of 322 patients with Barlow’s disease. To minimize biases, we exclusively analyzed patients with one specific semi-rigid annuloplasty ring. Cases with leaflet resection, concomitant CABG, or aortic valve procedures were excluded. The resulting cohort included 140 patients (Alfieri n = 47; neochordae n = 93). The baseline demographic and echocardiographic characteristics were comparable between groups. Perioperative mortality was 0% in both groups, and no significant differences were observed in complication rates (stroke, re-exploration for bleeding). Aortic cross-clamp time was significantly shorter ( p < 0.001) in the Alfieri group. No relevant transmitral gradient was detected postoperatively in either group, and no case of systolic anterior motion occurred. At a median FU of 4.7 years, only one patient in each cohort (Alfieri 2.1% vs. neochordae 1.1%) presented with more than moderate mitral regurgitation. At last FU, reoperation rates were equally low between neochordal ( n = 3) and Alfieri repair ( n = 1). Both cohorts demonstrated a low symptomatic burden (NYHA I–II) at last FU. Echocardiographic assessment showed left ventricular reverse remodeling without significant intergroup differences.
Conclusion
Both the Alfieri and neochordae techniques provided uniformly favorable perioperative outcomes, with improved functional status alongside LV reverse remodeling. Clinical and echocardiographic results were comparable, demonstrating lower cross-clamp time in edge-to-edge repair without compromising clinical safety or long-term durability. These findings support the use of the Alfieri technique as an equivalent alternative to neochordae repair in complex mitral valve pathology. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Steiner, K., Bozini, N., Lang, M., Soulis, S., Bichler, M., Bonk, M., Voss, S., Vitanova, K., Krane, M., & Sideris, K. (2026). From Bailout to Benchmark: Rethinking the Alfieri Procedure for Mitral Regurgitation in Barlow’s Disease. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817343
Vancouver
Steiner K, Bozini N, Lang M, Soulis S, Bichler M, Bonk M, et al. From Bailout to Benchmark: Rethinking the Alfieri Procedure for Mitral Regurgitation in Barlow’s Disease. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817343
BibTeX
@article{Steiner2026,
author = {Steiner, K. and Bozini, N. and Lang, M. and Soulis, S. and Bichler, M. and Bonk, M. and Voss, S. and Vitanova, K. and Krane, M. and Sideris, K.},
title = {From Bailout to Benchmark: Rethinking the Alfieri Procedure for Mitral Regurgitation in Barlow’s Disease},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817343}
}
EUVIMED